Wynnchurch Capital acquires Reagent Chemical & Research

Wynnchurch Capital, L.P. has announced the acquisition of Reagent Chemical & Research, LLC, a leading distributor of hydrochloric acid (HCl) in North America. Wynnchurch acquired Reagent in partnership with management as the company seeks to expand its market presence and drive future growth. The financial terms of the transaction remain undisclosed.

Key Details of the Acquisition

– Market Position: Reagent Chemical & Research, LLC, headquartered in Ringoes, New Jersey, leads North America’s hydrochloric acid distribution.

– Strategic Investment: The acquisition aligns with Wynnchurch’s approach to investing in companies with strong growth potential and market leadership.

– Operational Excellence: Reagent leverages specialized infrastructure and logistics capabilities to maintain its reputation for reliability, safety, and customer service.

Wynnchurch Capital has announced the acquisition of Reagent Chemical & Research, a distributor of hydrochloric acid (HCl) in North America.

Leadership Comments on Partnership

– Rob Lippert, CEO, Reagent: “Wynnchurch’s founder- and management-friendly approach made them the ideal partner.”

– Brian Crumbaugh, Partner, Wynnchurch: “Reagent’s value proposition, infrastructure, and market position impressed us. We are excited to partner with Rob and the team.”

– JD Frank, Principal, Wynnchurch: “Reagent is renowned for its high service levels and safety record. We are excited to support the team through the next phase of growth.”

Building upon Wynnchurch’s Recent Investments

Wynnchurch, managing private equity funds with $9.2 billion in regulatory assets, has been actively expanding its portfolio:

– Recent Acquisitions: The firm acquired Handgards, a distributor of foodservice products, in April 2024.

– Other Investments: FloWorks, Industrial Service Solutions, and FCA are recent investments that complement Wynnchurch’s strategic growth objectives.

Advisory Support

Paul Hastings LLP advised Wynnchurch, while Deloitte Corporate Finance LLC and McElroy, Deutsch, Mulvaney & Carpenter, LLP supported Reagent.